On Thursday, October 15, an agreement was signed at the Ministry of Pharmaceutical Industry between the Algerian company "Pharma Invest" and the Chinese "Yangtze River Pharmaceutical Group", under the supervision of Minister Ali Aoun. The partnership focuses on transferring advanced technology for the production of pharmaceutical raw materials and supporting the manufacture of innovative drugs to strengthen local industrial capabilities. Additionally, initial talks were held between the "Saidal" group and "Pharma Invest" to pave the way for a future agreement concerning the production and distribution of high-value-added medicines.